4.7 Article

PKC epsilon Regulates Contraction-Stimulated GLUT4 Traffic in Skeletal Muscle Cells

期刊

JOURNAL OF CELLULAR PHYSIOLOGY
卷 226, 期 1, 页码 173-180

出版社

WILEY
DOI: 10.1002/jcp.22320

关键词

-

资金

  1. Canadian Institutes of Health Research [FRN-82420, 30611120532]
  2. National Natural Science Foundation of China [FRN-82420, 30611120532, 30570912]
  3. Tianjin Municipal Science and Technology Commission [09ZCZDSF04500, 07JCZDJC07900]
  4. Canadian Diabetes Association
  5. Natural Sciences and Engineering Research Council of Canada

向作者/读者索取更多资源

The signaling pathways that stimulate glucose uptake in response to muscle contraction are not well defined. Recently, we showed that carbachol, an acetylcholine analog, stimulates contraction of C2C12 myotube cultures and the rapid arrival of myc-epitope tagged GLUT4 glucose transporters at the cell surface. Here, we explore a role for protein kinase C (PKC) in regulating GLUT4 traffic. Cell surface carbachol-induced GLUT4myc levels were partly inhibited by the conventional/novel PKC inhibitors GF-109203X, Go6983, and Ro-31-8425 but not by the conventional PKC inhibitor Go6976. C2C12 myotubes expressed several novel isoforms of PKC mRNA with PKC delta and PKC epsilon in greater abundance. Carbachol stimulated phosphorylation of PKC isoforms and translocation of PKC delta and PKC epsilon to membranes within 5 min. However, only a peptidic inhibitor of PKC epsilon translocation (myristoylated-EAVSLKPT), but not one of PKC delta (myristoylated-SFNSYELGSL), prevented the GLUT4myc response to carbachol. Significant participation of PKC epsilon in the carbachol-induced gain of GLUT4myc at the surface of C2C12 myotubes was further supported through siRNA-mediated PKC epsilon protein knockdown. These findings support a role for novel PKC isoforms, especially PKC epsilon, in contraction-stimulated GLUT4 traffic in muscle cells. J. Cell. Physiol. 226: 173-180, 2010. (C) 2010 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Physiology

Life-long exercise training and inherited aerobic endurance capacity produce converging gut microbiome signatures in rodents

Fernando F. Anhe, Soumaya Zlitni, Nicole G. Barra, Kevin P. Foley, Mats Nilsson, Joshua P. Nederveen, Lauren G. Koch, Steven L. Britton, Mark A. Tarnopolsky, Jonathan D. Schertzer

Summary: Exercise training and host genetics have similar effects on the gut microbiome in different rodent species during aging, suggesting that they can mitigate gut dysbiosis and functional decline.

PHYSIOLOGICAL REPORTS (2022)

Article Endocrinology & Metabolism

Metformin-induced reductions in tumor growth involves modulation of the gut microbiome

Lindsay A. Broadfield, Amna Saigal, Jake C. Szamosi, Joanne A. Hammill, Ksenia Bezverbnaya, Dongdong Wang, Jaya Gautam, Evangelia E. Tsakiridis, Fiorella Di Pastena, Jamie McNicol, Jianhan Wu, Saad Syed, James S. V. Lally, Amogelang R. Raphenya, Marie-Jose Blouin, Michael Pollak, Andrea Sacconi, Giovanni Blandino, Andrew G. McArthur, Jonathan D. Schertzer, Michael G. Surette, Stephen M. Collins, Jonathan L. Bramson, Paola Muti, Theodoros Tsakiridis, Gregory R. Steinberg

Summary: This study demonstrates that in obese mice fed a high-fat diet, metformin reduces tumor burden through changes in the gut microbiome. Fecal microbiome transfer or in vitro treatment with fecal filtrates from high-fat diet-fed animals partially recapitulates the acceleration of tumor growth. Oral administration of metformin suppresses tumor growth and increases the expression of short-chain fatty acid-producing microbes. Transplanting the gut microbiome from mice treated orally with metformin to drug naive obese mice reduces tumor proliferation and affects the expression of tumor-related genes.

MOLECULAR METABOLISM (2022)

Editorial Material Cell Biology

Dietary sugar lowers immunity and microbiota that protect against metabolic disease

Han Fang, Fernando F. Anhe, Jonathan D. Schertzer

Summary: This study demonstrates that dietary sugar can disrupt the balance of intestinal microbiota, lower protective immunity, and exacerbate metabolic diseases.

CELL METABOLISM (2022)

Article Gastroenterology & Hepatology

Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity

Fernando F. Anhe, Soumaya Zlitni, Song-Yang Zhang, Beatrice So-Yun Choi, Cassandra Y. Chen, Kevin P. Foley, Nicole G. Barra, Michael G. Surette, Laurent Biertho, Denis Richard, Andre Tchernof, Tony K. T. Lam, Andre Marette, Jonathan Schertzer

Summary: Exposure of rodents to human gut microbiota after restrictive or malabsorptive bariatric surgery improves glycaemic control independently from changes in obesity, insulin or insulin resistance. Higher Parabacteroides and lower Blautia coincided with improvements in blood glucose control after colonisation with human bacteria post-BPD-DS and LSG.
Review Endocrinology & Metabolism

Kinase inhibitors for cancer alter metabolism, blood glucose, and insulin

Brittany M. Duggan, Daniel M. Marko, Raveen Muzaffar, Darryl Y. Chan, Jonathan D. Schertzer

Summary: Small molecule kinase inhibitors (SMKIs) are therapeutic drugs that can target protein kinases and have effects on cell metabolism and endocrine control of organismal metabolism. They have been shown to improve blood glucose levels in diabetic cancer patients and reduce the dependence on insulin or diabetic medication.

JOURNAL OF ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Dietary Nitrate and Corresponding Gut Microbiota Prevent Cardiac Dysfunction in Obese Mice

Heather L. Petrick, Leslie M. Ogilvie, Henver S. Brunetta, Avery Robinson, Aleah J. Kirsh, Pierre-Andre Barbeau, Rachel M. Handy, Bridget Coyle-Asbil, Connor Gianetto-Hill, Kaitlyn M. J. H. Dennis, Luc J. C. van Loon, Adrian Chabowski, Jonathan D. Schertzer, Emma Allen-Vercoe, Jeremy A. Simpson, Graham P. Holloway

Summary: Impaired heart function in diabetes patients can be caused by factors other than hypertension, such as gut dysbiosis. Dietary nitrate and fecal microbial transplantation have been found to prevent high-fat diet-induced cardiac abnormalities by mitigating gut dysbiosis.

DIABETES (2023)

Editorial Material Gastroenterology & Hepatology

Obesity promotes a leaky gut, inflammation and pre-diabetes by lowering gut microbiota that metabolise ethanolamine

Han Fang, Rodrigo R. e-Lacerda, Jonathan D. Schertzer

Article Pediatrics

Associations of intrapartum antibiotics and growth, atopy, gastrointestinal and sleep outcomes at one year of age

Eileen D. Hutton, Julia C. Simioni, Lehana G. Thabane, Katherine Morrison, Alison C. Holloway, Helen McDonald, Elyanne M. Ratcliffe, Jonathan D. Schertzer, Jennifer C. Stearns, Mike G. Surette

Summary: This prospective study found that exposure to intrapartum antibiotics can affect infant outcomes related to growth, atopic disease, gastrointestinal symptoms, and sleep. In addition, intrapartum and early neonatal antibiotic exposure are associated with an increased risk of fungal infection. Therefore, the use of intrapartum and early neonatal antibiotics should be carefully considered, weighing the risks and benefits.

PEDIATRIC RESEARCH (2023)

Correction Pediatrics

Associations of intrapartum antibiotics and growth, atopy, gastrointestinal and sleep outcomes at one year of age (Feb, 10.1038/s41390023-02525-1, 2023)

Eileen D. Hutton, Julia C. Simioni, Lehana G. Thabane, Katherine Morrison

PEDIATRIC RESEARCH (2023)

Meeting Abstract Physiology

Does Obesity or Hyperglycemia Alter Metabolic Endotoxemia?

Arshpreet Bhatwa, Gabriel Anhe, Fernando Anhe, Jonathan Schertzer

PHYSIOLOGY (2023)

Meeting Abstract Physiology

Statins activate the NLRP3 inflammasome and inhibit the Hippo pathway to promote myopathy

Nazli Robin, Nicole Barra, Danish Patoli, Kevin Watt, Khang Nguyen, Kevin Foley, Yujin Li, Akhilesh Tamrakar, Irena Rebalka, Michael Huang, Rhianna Davis, Darryl Chan, Brittany Duggan, Brandyn Henriksbo, Paul Gregorevic, Gary Sweeney, Thomas Hawke, Benedicte Py, Jonathan Schertzer

PHYSIOLOGY (2023)

Meeting Abstract Physiology

Interferon regulatory factor 4 dictates metabolic flexibility of fat versus muscle loss during repeated intermittent fasting

Daniel Marko, Breanne McAlpin, Brittany Duggan, Joseph Cavallari, Jonathan Schertzer

PHYSIOLOGY (2023)

Correction Multidisciplinary Sciences

Chronic exposure to synthetic food colorant Allura Red AC promotes susceptibility to experimental colitis via intestinal serotonin in mice (vol 13, 7617, 2022)

Yun Han Kwon, Suhrid Banskota, Huaqing Wang, Laura Rossi, Jensine A. Grondin, Saad A. Syed, Yeganeh Yousefi, Jonathan D. Schertzer, Katherine M. Morrison, Michael G. Wade, Alison C. Holloway, Michael G. Surette, Gregory R. Steinberg, Waliul I. Khan

NATURE COMMUNICATIONS (2023)

Article Gastroenterology & Hepatology

Crohn's disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice

Alba Santiago, Amber Hann, Marco Constante, Sara Rahmani, Josie Libertucci, Kyle Jackson, Gaston Rueda, Laura Rossi, Ramachandran Rithwick, Wolfram Ruf, Jon Schertzer, Alberto Caminero, Premysl Bercik, Heather Jean Galipeau, Elena Francisca Verdu

Summary: Emerging evidence suggests that microbial proteolytic activity is implicated in ulcerative colitis (UC), but its role in Crohn's disease (CD) remains unclear. This study investigated the effects of colonizing germ-free mice with CD microbiota and healthy control microbiota. It was found that CD proteolytic microbiota increased colitis severity through a PAR2 pathway. These findings highlight the proinflammatory nature of CD proteolytic microbiota and its role in exacerbating colitis.

GUT MICROBES (2023)

Article Multidisciplinary Sciences

Intestinal permeability and peripheral immune cell composition are altered by pregnancy and adiposity at mid- and late-gestation in the mouse

Tatiane A. Ribeiro, Jessica A. Breznik, Katherine M. A. Kennedy, Erica S. Yeo, Brianna K. E. J. Kennelly, Patrycja A. F. Jazwiec, Violet S. D. Patterson, Christian J. Bellissimo, Fernando F. M. Anhe, Jonathan D. Schertzer, Dawn M. E. Bowdish, Deborah M. Sloboda

Summary: This study found that pregnancy and diet have an impact on maternal intestinal structure and barrier function, as well as peripheral immunophenotype. High-fat diet can worsen the effects of pregnancy on the gut and immune system. Excess maternal adiposity can negatively influence both maternal and child health.

PLOS ONE (2023)

暂无数据